There is an evident rise in the demand for effective, non-invasive drug delivery systems that are capable of overcoming bioavailability hurdles and enable delivery of the drug at the target cells, at effective concentrations, for a suitable period of time. In our research, 50 drug delivery devices that have been / are being developed by various industry players across the world.

To order this detailed 180+ page report, please visit this - https://www.rootsanalysis.com/reports/novel-ocular-drug-delivery-devices-market.html

The novel ocular drug delivery market is highly fragmented, featuring the presence of established, as well as emerging players. Further, majority (75%) of the developers engaged in this domain are based in North America; examples, include (in alphabetical order) Aerie Pharmaceuticals, Alimera Sciences, Amorphex Therapeutics, Bausch and Lomb, EyePoint Pharmaceuticals and Genentech. This is followed by players headquartered in RoW (13%), Asia Pacific (6%) and Europe (6%).

To Request for sample - https://www.rootsanalysis.com/reports/novel-ocular-drug-delivery-devices-market/request-sample.html

You may also be interested in the following titles:

1.     Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020 - 2030

2.     China Biopharmaceutical Contract Manufacturing Market, 2020-2030

3.     Antibody Contract Manufacturing Market, 2020 - 2030

Contact Details

Ben Johnson

+1 (415) 800 3415

[email protected]

Roots Analysis

Web: https://www.rootsanalysis.com/

LinkedIn: https://in.linkedin.com/company/roots-analysis

Twitter: https://twitter.com/RootsAnalysis.com

Medium: https://medium.com/@RootsAnalysis

Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/

Quora: https://rootsanalysisinsights.quora.com/